Summary
Introduction
Squamous cell carcinoma is the most frequent histological form of malignant tumors of the larynx. Its association with B-cell chronic lymphocytic leukemia (CLL) has only rarely been reported in the literature [1] .
We report an exceptional observation of the association of squamous cell carcinoma of the larynx and CLL. The latter raised classification and therapeutic management difficulties.
The objective of this study was to discuss the epidemiological characteristics of the association of larynx carcinoma and CLL, present the treatment problems as well as the effects on prognosis.
Observation
The 75-year-old patient, a smoker of 80 packs a year with a history of coronary disease, consulted for dys- phonia evolving over 6 months with undefined weight loss.
Examination showed a tumor of the right hemilarynx with fixity of the right vocal cord and bilateral upper and midcervical jugulocarotid adenopathies.
Direct laryngoscopy demonstrated a tumor of the vocal cord extending to the ventricle and the ventricular band on the right side. The biopsy concluded in squamous cell carcinoma. The cervical CT scan showed a hypodense tumor process invading the right glottosupraglottic region with involvement of the hyothyroepiglottic space and the right paraglottic region associated with bilateral cervical adenopathies. Staging (chest x-ray and cervical ultrasound) was negative. The tumor was classified T3N2bM0. Total laryngectomy with bilateral modified radical cervical evidement was performed.
The anatomopathological examination of the operative specimen showed invasion of the right hemilarynx by a moderately differentiated squamous cell carcinoma. However, there was a diffuse and nodular infiltration comprising small, mature monomorphic lymphocytes in the healthy laryngeal tissue and in contact with the carcinomatous proliferation ( Figs. 1 and 2 ). Carcinomatous invasion with capsular rupture was noted in two lymph nodes out of 38. None of the 38 lymph node samples on the left was the seat of metastasis of the squamous cell carcinoma. However, all the lymph nodes with no carcinomatous infiltration were the seat of diffuse lymphomatous proliferation, with the same characteristics as described for the larynx. Immunophenotyping of the B lymphocytes concluded in Bcell CLL.
The disease course was marked by the appearance on the 15th postoperative day of left-sided submandibular and inguinal adenopathies without hepatosplenomegaly.
The postoperative report found hyperleukocytosis at 20,000 with lymphocytosis at 15,000 lymphocytes/mm 3 with neither anemia nor thrombopenia.
Imaging studies (cervical ultrasound and thoracoabdominopelvic CT) demonstrated several bilateral and mediastinal submandibular adenopathies. This CLL was classified stage B in the Binet classification (Table 1) . Telecobalt therapy was used to deliver a 50-Gy dose in the tumor bed and in the cervical lymph node area at 2 Gy per session and five sessions per week. The dose was completed to 60 Gy in the metastatic cervical lymph node areas with capsular rupture. Chemotherapy was declined in this patient because of his age and his cardiac disease.
Discussion
CLL is a chronic hemopathy defined by the accumulation of small B lymphocytes in the blood and bone marrow, with a mature aspect of monoclonal origin presenting a characteristic phenotype. It is characterized by three major distinctive traits:
(1) it is not a proliferative disease but rather a dysregulation of apoptosis. The best-known apoptosis inhibitor gene is BCL-2, located on chromosome 18. In CLL, this gene is nearly always overexpressed. Its mechanism of action remains unexplained and its involvement in apoptosis inhibition has not been clarified. However, this apoptosis leads to an accumulation of B-cells;
(2) autoimmune phenomena are frequent, mainly directed against hematopoietic cells. Therefore, these manifestations result from autoantibodies (polyclonal immunoglobulins G). These autoantibodies are directed against the hematopoietic cell lines and are responsible for autoimmune hemolytic anemia, thrombopenia, and more rarely autoimmune neutropenia; (3) there is a severe immune deficit, notably hypogammaglobulinemia worsening as the disease progresses [2] .
CLL is the most frequent leukemia in Western countries. It increases with age, with the median age around 65 years. Genetic factors seem to play a role in the pathogenesis of the disease. Karyotype abnormalities are found in 50 to 80% of cases. These abnormalities generally correspond to gains or losses of genetic material. The 13q14 deletion is the most frequent. The 11q22-23 deletions, trisomy 12, and p53 mutation or deletion on chromosome 17 are associated with more aggressive forms [2] .
CLL seems to favor the onset of synchronous or metachronous epithelial cancers. A review of the literature showed that in a population of 10,823 patients with CLL, 9% developed a second synchronous or metachronous cancer [3] . The association of CLL and squamous cell carcinomas of the upper aerodigestive tract (UADT) is not exceptional. Karchmer et al. reported a 6.8% rate of cancers preceding or associated with leukemia, 22.5% of which were squamous cell carcinomas of the UADT [4] .
Synchronous or metachronous squamous cell carcinoma of the larynx and CLL has rarely been reported in the literature [1, 5, 6] . In a Danish study, combining more than 12,000 patients with CLL, the onset of the second cancer was noted in 1105 cases. In this group, the association of CLL and cancer of the larynx was observed in 0.8% of the cases [6] .
Different hypotheses can explain the relation between CLL and squamous cell carcinoma: alteration of antitumor immunity related to the presence of CLL due to dysfunction of the B-cells, a common etiological factor such as a genetic predisposition [2] , infection with an oncogene virus (HPV-16, -11, -6 and HHV-8) [7] , environmental exposure to cancerigenic chemicals, and immunodepression induced by chemotherapy [8] . The incidence of cervicofacial cancer onset in immunodepressed patients (e.g., subjects having received a transplant) varies in the literature from 1 to 2.4% with a follow-up of more than 10 years. The most frequent histological type was squamous cell carcinoma [9] .
The relation between smoking and CLL has not been proven, contrary to cancer of the larynx. However, the high prevalence of secondary cancers (particularly malignant tumors of the UADT, the pancreas, and the urinary system) in patients with CLL can be explained by smoking [6] . This tobacco intoxication was found in our patient.
Synchronous involvement of the lymph nodes makes clinical classification of the lymph node involvement difficult. An anatomopathological examination in this case provides precise lymph node staging [8] . Boddie et al. encountered problems in lymph node classification in 48% of the cases in 20 patients with cervicofacial squamous cell carcinoma and CLL with cervical lymph node infiltration [10] .
In general, in cases of synchronous tumors, the first-line treatment should focus on the tumor with the worst prognosis. In synchronous CLL and cervicofacial squamous cell carcinoma, treatment usually first aims to fight the carcinoma [8] .
In our case, CLL was discovered on the histological examination of a total laryngectomy associated with bilateral functional curettage for a squamous cell carcinoma of the larynx. The adjuvant treatment was prescribed for the carcinomatous involvement.
Conclusion
The association of CLL and UADT carcinomas has been well documented in the literature. However, the simultaneous coexistence of squamous cell carcinoma and CLL of the larynx remains extremely rare. We have described this association through a case study involving both the larynx and the lymph nodes. CLL was discovered at the histological examination. The strategy in these cases consists in treating the most aggressive cancer first. The prognosis is more negative compared to a single cancer of the larynx.
